{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:59:45Z","timestamp":1790200785746,"version":"4.1.0"},"reference-count":63,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2024,7,3]]},"DOI":"10.1080\/1120009x.2023.2297095","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T08:17:48Z","timestamp":1703751468000},"page":"355-369","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Fixed-dose antiretroviral combinations in children living with human immunodeficiency virus type 1 (HIV-1): a systematic review"],"prefix":"10.1080","volume":"36","author":[{"given":"Federica","family":"Attaianese","sequence":"first","affiliation":[{"name":"Department of Health Sciences, Section of Paediatrics, University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Dalpiaz","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Section of Paediatrics, University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Failla","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Section of Paediatrics, University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Pasquali","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Section of Paediatrics, University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Galli","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Section of Paediatrics, University of Florence","place":["Florence, Italy"]},{"name":"Paediatric Infectious Disease Unit, IRCCS Anna Meyer Children\u2019s Hospital","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Chiappini","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Section of Paediatrics, University of Florence","place":["Florence, Italy"]},{"name":"Paediatric Infectious Disease Unit, IRCCS Anna Meyer Children\u2019s Hospital","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,12,28]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-020-00486-2"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31311-4"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-021-01005-1"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001335"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26175305"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2017.00032"},{"key":"e_1_3_2_8_1","volume-title":"HIV antiretroviral therapy","author":"Kemnic TR","year":"2023","unstructured":"Kemnic TR, Gulick PG. HIV antiretroviral therapy. Treasure Island (FL): StatPearls Publishing; 2023. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK513308\/"},{"key":"e_1_3_2_9_1","unstructured":"World Health Organization. HIV\/AIDS fact sheets key facts. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids"},{"key":"e_1_3_2_10_1","unstructured":"UNAIDS. Data. 2021. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2021-global-aids-update_en.pdf."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.2165\/00148581-200507030-00001"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsn068"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/2325958218774782"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12343"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2010.0181"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07026-w"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijstd.IJSTD_43_18"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-14-114"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1393331"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1931115"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-014-0024-z"},{"key":"e_1_3_2_22_1","unstructured":"European AIDS Clinical Society Guidelines. Version 11.0. 2021."},{"key":"e_1_3_2_23_1","unstructured":"European Medicine Agency. Italian national register of authorised medicines. https:\/\/www.ema.europa.eu\/en\/medicines\/national-registers-authorised-medicines"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000701"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000158"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1654938"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2008.03.018"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e3282ced12c"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2014.925879"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_3_2_31_1","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.3","author":"Higgins JPT","year":"2022","unstructured":"Higgins JPT, Savovi\u0107 J, Page MJ, et\u00a0al. Chapter 8: assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions version 6.3. 2022. www.training.cochrane.org\/handbook."},{"key":"e_1_3_2_32_1","unstructured":"NIH Study Quality Assessment Tools. Bethesda MD 20892. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools"},{"key":"e_1_3_2_33_1","unstructured":"More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents (MOCHA). NCT03497676. www.clinicaltrial.gov"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000003116"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000633"},{"key":"e_1_3_2_36_1","unstructured":"Brooks KM Kiser JJ Samson P et\u00a0al. IMPAACT 2019 Team. Pharmacokinetics and safety of dispersible and immediate release FDC Abacavir\/Dolutegravir\/Lamivudine in children with HIV weighing = 14\u2009kg: preliminary results from IMPAACT 2019. IAS 2021 and international workshop on HIV pediatrics. 2021. https:\/\/www.impaactnetwork.org\/news\/2021\/impaact-2019-results-released"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2011.596511"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(21)00165-6"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(16)30121-7"},{"key":"e_1_3_2_40_1","unstructured":"Gaur AH Fourie J Chokephaibulkit K et\u00a0al. Pharmacokinetics efficacy and safety of an integrase Inhibitor-Based single-tablet regimen in HIV-Infected treatment-na\u00efve adolescents. 21st Conference on Retroviruses and Opportunistic Infections (CROI). Boston MA USA. 2014. https:\/\/www.natap.org\/2014\/CROI\/croi_176.htm"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(17)30009-3"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000222415.40563.d4"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902824"},{"key":"e_1_3_2_44_1","unstructured":"An Open-label. Single Arm Study to Evaluate the Week 48 Efficacy and Safety of a Two-drug Regimen of Dolutegravir\/Lamivudine (DTG\/3TC) as a Fixed Dose Combination (FDC) in Antiretroviral Therapy (ART)-Naive HIV-1-infected Adolescents \u226512 to <18 Years of Age Who Weigh at Least 25\u2009kg. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT03682848"},{"key":"e_1_3_2_45_1","unstructured":"A Randomised Non-inferiority Trial With Nested PK to Assess DTG\/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04337450"},{"key":"e_1_3_2_46_1","unstructured":"Crawels H Chetty P Opsomer M et\u00a0al. Assessment of the acceptability and swallowability of darunavir-containing Fixed-dose Combination (FDC) tablets in adolescents living with HIV-1 using matched placebo tablets. Presented at the HIV glasgow drug therapy meeting NCT02993237. 2018. https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jia2.25187"},{"key":"e_1_3_2_47_1","unstructured":"A Phase 2\/3 Open-Label. Multi-cohort switch study to evaluate Emtricitabine\/Tenofovir Alafenamide (F\/TAF) in HIV-1 infected children and adolescents virologically suppressed on a 2-NRTI-containing regimen. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02285114"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0906768"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62198-9"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003842"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx235"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13341"},{"key":"e_1_3_2_53_1","unstructured":"Brooks KM Kiser JJ Rani Y et\u00a0al. IMPAACT 2019 Team. IMPAACT 2019: PK & safety of dispersible ABC\/DTG\/3TC in children with HIV 6 to < 14\u2009kg. CROI 2022. https:\/\/www.impaactnetwork.org\/news\/2022\/impaact-shares-study-results-croi-2022-poster-presentations"},{"key":"e_1_3_2_54_1","unstructured":"Cotton M Liberty A Rodriguez CA et\u00a0al. Pharmacokinetics safety and efficacy of bictegravir\/emtricitabine\/tenofovir alafenamide (B\/F\/TAF) single-tablet regimen in HIV-1-infected children (6 to < 12 years). Presented at: International AIDS Conference. Amsterdam Netherlands. 2018. http:\/\/www.natap.org\/2018\/IAC\/IAC_39.htm"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32299-7"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027330"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32340-1"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/15284336.2019.1589232"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019896638"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13562"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa285"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-022-00608-1"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570162X20666220608160335"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1159\/000506181"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1120009X.2023.2297095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T04:46:40Z","timestamp":1757566000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1120009X.2023.2297095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,28]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,7,3]]}},"alternative-id":["10.1080\/1120009X.2023.2297095"],"URL":"https:\/\/doi.org\/10.1080\/1120009x.2023.2297095","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yjoc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yjoc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-03-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}